Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Belite Bio, Inc - American Depositary Shares (NQ:BLTE)

161.98 -7.04 (-4.17%)
Streaming Delayed Price Updated: 11:09 AM EST, Jan 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Belite Bio, Inc - American Depositary Shares

< Previous 1 2 3 4 Next >
News headline image
Why Belite Bio Stock Soared on Monday ↗
The company is now tantalizingly close to commercializing its leading drug candidate. 
Via The Motley Fool
News headline image
Top movers in Monday's pre-market session ↗
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Earnings Scheduled For November 10, 2025 ↗
 
Via Benzinga
News headline image
Earnings Outlook For Belite Bio ↗
 
Via Benzinga
News headline image
3 Lesser-Known Healthcare Names With Major Upside in Store ↗
These are three healthcare stocks offering a compelling combination of secure business, strong fundamentals, and growth opportunity. 
Via MarketBeat
News headline image
Belite Bio's Earnings Outlook ↗
 
Via Benzinga
News headline image
Earnings Outlook For Belite Bio ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
Insights into Belite Bio's Upcoming Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 11, 2025 ↗
 
Via Benzinga
News headline image
Dycom Industries Posts Upbeat Earnings, Joins WeRide, Keysight Technologies And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Belite Bio Analysts See Potential For Stock Gains With Progress In Key Trials ↗
Belite Bio Inc (NASDAQ: BLTE) stock falls after reporting Q3 net loss of $36.1M; analysts maintain Buy/Overweight rating, citing positive trial results. 
Via Benzinga
News headline image
Earnings Scheduled For March 17, 2025 ↗
 
Via Benzinga
News headline image
Expert Ratings for Belite Bio ↗
 
Via Benzinga
News headline image
Expert Ratings for Belite Bio ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Belite Bio ↗
 
Via Benzinga
News headline image
Analyst Expectations for Belite Bio's Future ↗
 
Via Benzinga
News headline image
BLTE Stock Earnings: Belite Bio Misses EPS for Q2 2024 ↗
BLTE stock results show that Belite Bio missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
BLTE Stock Earnings: Belite Bio Misses EPS for Q1 2024 ↗
BLTE stock results show that Belite Bio missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023 ↗
 
Via Benzinga
News headline image
Why Shares of Belite Bio Soared This Week ↗
The clinical-stage biotech company bounced back from a 52-week low late last week. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  Friday's session saw 32 companies set new 52-week lows. 
Via Benzinga
News headline image
Top 5 Health Care Stocks That Are Set To Fly In Q2 ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.